Japan · Delayed Price · Currency is JPY Kidswell Bio Statistics
Total Valuation
Kidswell Bio has a market cap or net worth of JPY 9.10 billion. The enterprise value is 8.35 billion.
| Market Cap | 9.10B |
| Enterprise Value | 8.35B |
Important Dates
The last earnings date was Thursday, August 13, 2026.
| Earnings Date | Aug 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Kidswell Bio has 50.58 million shares outstanding. The number of shares has increased by 3.56% in one year.
| Current Share Class | 50.58M |
| Shares Outstanding | 50.58M |
| Shares Change (YoY) | +3.56% |
| Shares Change (QoQ) | +1.84% |
| Owned by Insiders (%) | 4.41% |
| Owned by Institutions (%) | -1.34% |
| Float | 36.17M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 8.23 |
| PS Ratio | 1.48 |
| PB Ratio | 4.96 |
| P/TBV Ratio | 4.96 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.36 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.73, with a Debt / Equity ratio of 1.35.
| Current Ratio | 2.73 |
| Quick Ratio | 1.81 |
| Debt / Equity | 1.35 |
| Debt / EBITDA | n/a |
| Debt / FCF | -2.22 |
| Interest Coverage | -1.72 |
Financial Efficiency
Return on equity (ROE) is -19.21% and return on invested capital (ROIC) is -10.85%.
| Return on Equity (ROE) | -19.21% |
| Return on Assets (ROA) | -1.06% |
| Return on Invested Capital (ROIC) | -10.85% |
| Return on Capital Employed (ROCE) | -2.71% |
| Weighted Average Cost of Capital (WACC) | 8.90% |
| Revenue Per Employee | 191.79M |
| Profits Per Employee | -11.66M |
| Employee Count | 32 |
| Asset Turnover | 0.97 |
| Inventory Turnover | 6.83 |
Taxes
In the past 12 months, Kidswell Bio has paid 31.51 million in taxes.
| Income Tax | 31.51M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -24.69% in the last 52 weeks. The beta is 1.19, so Kidswell Bio's price volatility has been higher than the market average.
| Beta (5Y) | 1.19 |
| 52-Week Price Change | -24.69% |
| 50-Day Moving Average | 149.08 |
| 200-Day Moving Average | 210.35 |
| Relative Strength Index (RSI) | 71.72 |
| Average Volume (20 Days) | 323,045 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Kidswell Bio had revenue of JPY 6.14 billion and -373.13 million in losses. Loss per share was -7.56.
| Revenue | 6.14B |
| Gross Profit | 1.36B |
| Operating Income | -107.65M |
| Pretax Income | -341.62M |
| Net Income | -373.13M |
| EBITDA | n/a |
| EBIT | -107.65M |
| Loss Per Share | -7.56 |
Balance Sheet
The company has 3.23 billion in cash and 2.48 billion in debt, with a net cash position of 758.00 million or 14.99 per share.
| Cash & Cash Equivalents | 3.23B |
| Total Debt | 2.48B |
| Net Cash | 758.00M |
| Net Cash Per Share | 14.99 |
| Equity (Book Value) | 1.84B |
| Book Value Per Share | 37.00 |
| Working Capital | 3.73B |
Cash Flow
In the last 12 months, operating cash flow was -1.10 billion and capital expenditures -17.00 million, giving a free cash flow of -1.11 billion.
| Operating Cash Flow | -1.10B |
| Capital Expenditures | -17.00M |
| Depreciation & Amortization | n/a |
| Net Borrowing | 1.09B |
| Free Cash Flow | -1.11B |
| FCF Per Share | -22.00 |
Margins
Gross margin is 22.09%, with operating and profit margins of -1.75% and -6.08%.
| Gross Margin | 22.09% |
| Operating Margin | -1.75% |
| Pretax Margin | -5.57% |
| Profit Margin | -6.08% |
| EBITDA Margin | n/a |
| EBIT Margin | -1.75% |
| FCF Margin | n/a |
Dividends & Yields
Kidswell Bio does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.56% |
| Shareholder Yield | -3.56% |
| Earnings Yield | -4.10% |
| FCF Yield | -12.22% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on June 27, 2018. It was a forward split with a ratio of 2.
| Last Split Date | Jun 27, 2018 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
Kidswell Bio has an Altman Z-Score of 3.05 and a Piotroski F-Score of 1.
| Altman Z-Score | 3.05 |
| Piotroski F-Score | 1 |